Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details) - shares	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	33,348,844	2,613,694
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	6,150,494	2,585,361
Placement agent warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	28,333	28,333
Time based Stock Appreciation Rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	496,679	0
Stock Appreciation Rights from exercised Series B Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	23,077	0
Potential additional Stock Appreciation Rights from Series B Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	384,694	0
February 2026 common warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	22,907,600	0
Series B Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	3,357,967	0